IOVANCE BIOTHERAPEUTICS, INC.

IOVA

IOVANCE BIOTHERAPEUTICS, INC.

IOVA

Insider Sentiment (TTM):

Last Purchase:2025-06-05Last Sale:2024-11-12Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:256,778,334Shares Outstanding:418,511,000Institutional Ownership Pct.:61.36%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Series A Preferred Stock	-	0	0	0	0	0	0	0	0	0	0	0
Series B Preferred Stock	-	2	2	0	0	2	3	0	0	3	3	0
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	111	197	163	158	132	172	116	164	229	134	115	268
Restricted Cash Current	-	-	-	-	-	1	-	-	-	-	-	-
Accounts Receivable Net Current	102	82	82	67	60	71	69	-	-	0	0	-
Short Term Investments	187	117	134	143	169	188	208	-	-	222	165	94
Inventory Net	56	58	52	52	50	66	52	-	-	18	10	9
Prepaid Expense And Other Assets Current	9	13	12	10	12	16	12	-	-	11	17	12
Assets Current	464	467	443	429	423	513	457	-	-	386	308	383
Property Plant And Equipment Net	131	131	131	127	122	112	109	-	-	112	114	113
Finite Lived Intangible Assets Net	264	269	279	285	296	285	282	-	-	294	229	224
Operating Lease Right Of Use Asset	43	44	46	49	50	51	55	-	-	72	63	66
Restricted Cash	-	-	-	-	-	-	-	-	-	6	66	66
Restricted Cash Noncurrent	6	6	6	6	6	6	6	-	-	-	66	-
Other Assets Noncurrent	6	8	8	9	10	0	0	-	-	0	0	0
Assets	916	926	913	905	907	967	910	-	-	870	780	852
Liabilities And Stockhold…
Accrued Liabilities Current	-	-	-	-	-	-	-	-	-	46	69	61
Liabilities Current
Accounts Payable Current	26	37	22	31	32	28	28	-	-	26	33	19
Accrued Liabilities And Other Liabilities	78	88	111	87	89	85	82	-	-	-	69	-
Notes Payable Current	-	1	1	1	1	1	-	-	-	-	-	-
Operating Lease Liability Current	3	3	4	6	7	8	13	-	-	11	8	10
Liabilities Current	107	129	138	126	129	123	122	-	-	83	110	91
Liabilities Noncurrent
Operating Lease Liability Noncurrent	43	44	44	45	45	44	44	-	-	72	67	68
Deferred Income Tax Liabilities Net	29	31	32	32	35	32	32	-	-	33	17	18
Long Term Notes Payable	-	-	-	-	-	-	1	-	-	1	1	1
Liabilities Noncurrent	73	74	76	77	80	76	78	-	-	107	85	87
Liabilities	179	204	215	203	209	199	200	-	-	190	196	178
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	-	-	0	0	0
Accumulated Other Comprehensive Income Loss Net Of…	13	13	16	16	21	6	-1	-	-	0	3	-9
Additional Paid In Capital	3,625	3,564	3,458	3,390	3,290	3,262	3,096	-	-	2,805	2,594	2,579
Retained Earnings Accumulated Deficit	-2,902	-2,855	-2,776	-2,704	-2,612	-2,501	-2,385	-	-	-2,125	-2,012	-1,896
Stockholders Equity	736	722	699	702	698	768	710	773	769	680	585	674
Liabilities And Stockholders Equity	916	926	913	905	907	967	910	-	-	870	780	852
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	-	-	0	0	0
Common Stock Shares Authorized	650	500	500	500	500	500	500	-	-	500	500	500
Common Stock Shares Issued	453	438	412	385	342	334	305	-	-	280	256	256
Shares Outstanding	453	438	412	385	342	334	305	-	-	280	256	256

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	15.49%	19.72%	40.56%	-	-	-	-	-	-	-	-	-
2025	-44.79%	-46.69%	-1.26%	-15.53%	-20.08%	-14.77%	6.93%	23.38%	14.29%	-2.38%	2.12%	-8.73%
2024	-33.98%	-40.37%	-31.23%	46.85%	21.03%	34.38%	-24.10%	-39.98%	-49.10%	-32.70%	-41.83%	-68.44%
2023	-	-	-	-13.87%	-36.27%	-50.98%	44.91%	88.19%	75.69%	-13.83%	-35.11%	-41.25%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.35	3.60	3.20	3.41	3.27	4.18	3.74	4.22	5.15	4.63	2.79	4.21
Quick Ratio	3.74	3.05	2.74	2.92	2.80	3.51	3.21	3.84	4.74	4.28	2.54	3.97
Working Capital	357.41M	337.08M	304.33M	303.31M	293.35M	389.96M	334.68M	380.52M	388.62M	302.32M	197.54M	291.63M
Leverage & Debt
Debt to Equity	0.24	0.28	0.31	0.29	0.30	0.26	0.28	0.28	0.25	0.28	0.33	0.26
Debt Ratio	0.20	0.22	0.23	0.22	0.23	0.21	0.22	0.22	0.20	0.22	0.25	0.21
Efficiency & Turnover
Asset Turnover TTM	0.36	0.30	0.29	0.26	0.26	0.23	0.19	0.10	0.04	0.00	0.00	0.00
Days Sales Outstanding TTM	91.01	97.57	105.13	89.29	69.17	61.07	77.30	224.03	176.18	44.86	46.35	-
Receivables Turnover TTM	4.01	3.74	3.47	4.09	5.28	5.98	4.72	1.63	2.07	8.14	7.87	-
Per Share Metrics
Diluted EPS TTM	-0.64	-0.85	-1.09	-	-1.17	-1.16	-1.28	-1.35	-1.55	-1.69	-1.89	-1.76
Free Cash Flow Per Share TTM	-0.66	-0.73	-0.94	-0.97	-0.97	-1.08	-1.26	-1.23	-1.41	-1.52	-1.63	-1.53
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	48.40%	39.44%	34.28%	38.83%	39.46%	39.49%	43.17%	17.99%	-44.43%	-846.22%	-	-
Operating Profit Margin TTM	-92.72%	-127.16%	-153.08%	-166.31%	-170.02%	-187.50%	-240.92%	-473.22%	-1,401.36%	-24,549.63%	-38,734.99%	-63,131.40%
Net Profit Margin TTM	-89.09%	-123.90%	-148.38%	-158.78%	-161.44%	-176.49%	-226.84%	-451.25%	-1,343.27%	-23,615.70%	-37,345.42%	-61,241.44%
Growth Metrics
Net Revenue Growth (1Y)	34.55%	34.29%	60.60%	175.62%	636.99%	11,070.12%	13,698.99%	12,751.20%	13,669.75%	-	-	-
Net Income Growth (1Y)	-25.75%	-5.73%	5.05%	-3.02%	-11.43%	-16.52%	-16.18%	-5.31%	5.10%	9.23%	12.16%	11.05%
EPS Growth (1Y)	-44.83%	-27.27%	-14.78%	-19.21%	-24.58%	-31.17%	-32.01%	-23.25%	-17.16%	-12.32%	-24.03%	-28.71%
Valuation Metrics
P/E TTM	-6.47	-4.15	-2.50	-1.99	-1.48	-2.86	-5.76	-6.95	-5.19	-8.77	-4.31	-2.58
P/B TTM	2.54	2.04	1.40	1.12	0.82	1.40	3.02	3.68	2.97	5.80	3.27	1.66
P/S TTM	5.76	5.14	3.70	3.15	2.38	5.06	13.07	31.34	69.70	2,072.15	1,607.75	1,581.99
Market Cap	1.87B	1.47B	975.55M	789.96M	575.36M	1.08B	2.15B	2.85B	2.28B	3.95B	1.91B	1.12B
Enterprise Value	1.76B	1.27B	807.49M	626.86M	437.95M	898.10M	2.02B	2.68B	2.06B	3.81B	1.73B	851.75M
Calculated Values
Free Cash Flow TTM	-296.40M	-305.02M	-336.24M	-351.82M	-323.54M	-347.50M	-364.05M	-374.08M	-400.48M	-405.08M	-384.11M	-377.30M
Net Debt	-116.77M	-201.50M	-168.06M	-163.10M	-137.41M	-177.05M	-121.05M	-163.19M	-227.68M	-139.62M	-180.32M	-266.72M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-06-05Purchase

Owner: Kirby, Daniel Gordon

Title: Chief Commercial Officer

Shares: 30,000

Price/Share: $1.84

Value: $55,200.00

Shares Owned: 30,000

Relationship: Officer

Ownership: Direct

2025-05-23Purchase

Owner: Puri, Raj K.

Title: Chief Regulatory Officer

Shares: 5,600

Price/Share: $1.74

Value: $9,744.00

Shares Owned: 206,852

Relationship: Officer

Ownership: Direct

2025-05-14Purchase

Owner: Vogt, Frederick G

Title: Interim CEO & General Counsel

Shares: 25,000

Price/Share: $1.69

Value: $42,250.00

Shares Owned: 374,646

Relationship: Director,Officer

Ownership: Direct

2024-11-12Sale

Owner: Maynard, Ryan D

Title: -

Shares: 50,000

Price/Share: $10.06

Value: $503,000.00

Shares Owned: 7,500

Relationship: Director

Ownership: Direct

2024-02-20Purchase

Owner: Rothbaum, Wayne P.

Title: -

Shares: 5,000,000

Price/Share: $9.15

Value: $45,750,000.00

Shares Owned: 28,067,333

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-06-05	Kirby, Daniel Gordon	Officer	Chief Commercial Officer	Direct	Purchase	30,000	1.84	$55,200.00	30,000	4
2025-05-23	Puri, Raj K.	Officer	Chief Regulatory Officer	Direct	Purchase	5,600	1.74	$9,744.00	206,852	4
2025-05-14	Vogt, Frederick G	Director,Officer	Interim CEO & General Counsel	Direct	Purchase	25,000	1.69	$42,250.00	374,646	4
2024-11-12	Maynard, Ryan D	Director	-	Direct	Sale	50,000	10.06	$503,000.00	7,500	4
2024-02-20	Rothbaum, Wayne P.	Director	-	Indirect	Purchase	5,000,000	9.15	$45,750,000.00	28,067,333	4
2024-02-20	Dukes, Iain D.	Director	-	Direct	Purchase	32,000	9.15	$292,800.00	54,000	4
2024-02-20	Mcpeak, Merrill A	Director	-	Direct	Purchase	250,000	9.15	$2,287,500.00	320,150	4
2023-09-18	Mcpeak, Merrill A	Director	-	Indirect	Purchase	10,000	5.56	$55,600.00	248,633	4
2023-09-15	Rothbaum, Wayne P.	Director	-	Indirect	Purchase	5,000,000	5.30	$26,500,000.00	23,067,333	4
2022-12-21	Mcpeak, Merrill A	Director	-	Direct	Purchase	10,000	6.15	$61,500.00	70,150	4
2022-12-02	Rothbaum, Wayne P.	Director	-	Indirect	Purchase	10,000,000	6.50	$65,000,000.00	18,067,333	4
2022-11-29	Mcpeak, Merrill A	Director	-	Indirect	Purchase	10,000	6.31	$63,100.00	238,633	4
2022-11-28	Mcpeak, Merrill A	Director	-	Indirect	Purchase	10,000	6.18	$61,800.00	228,633	4
2022-11-28	Vogt, Frederick G	Officer	Interim CEO & General Counsel	Direct	Purchase	1,000	5.98	$5,980.00	2,000	4
2022-11-23	Dukes, Iain D.	Director	-	Direct	Purchase	10,000	6.10	$61,000.00	22,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

61.36%

Inst. Shares: 256,778,334

Shares Outstanding: 418,511,000

2025-12-31

70.72%

Inst. Shares: 252,712,677

Shares Outstanding: 357,345,000

2025-09-30

57.20%

Inst. Shares: 208,239,134

Shares Outstanding: 364,037,000

2025-06-30

64.14%

Inst. Shares: 214,564,439

Shares Outstanding: 334,511,000

2025-03-31

71.05%

Inst. Shares: 229,384,251

Shares Outstanding: 322,868,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	256,778,334	418,511,000	61.36%
2025-12-31	252,712,677	357,345,000	70.72%
2025-09-30	208,239,134	364,037,000	57.20%
2025-06-30	214,564,439	334,511,000	64.14%
2025-03-31	229,384,251	322,868,000	71.05%
2024-12-31	228,671,744	289,877,000	78.89%
2024-09-30	221,290,653	303,269,000	72.97%
2024-06-30	222,157,468	284,817,000	78.00%
2024-03-31	205,485,999	266,220,000	77.19%
2023-12-31	199,337,195	235,131,000	84.78%
2023-09-30	201,580,384	245,817,000	82.00%
2023-06-30	188,795,155	224,481,000	84.10%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) — SEC Financial Statements & Analysis

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) is a biological products, (no diagnostic substances) company, incorporated in DE. IOVANCE BIOTHERAPEUTICS, INC. trades on Nasdaq as: IOVA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), IOVANCE BIOTHERAPEUTICS, INC. reported a 34.55% year-over-year revenue growth, a Gross Profit Margin of 48.40% (TTM), a Debt-to-Equity ratio of 0.24x, a Price-to-Sales (P/S) ratio of 5.76x (TTM), a Price-to-Book (P/B) ratio of 2.54x (TTM), at a market cap of $1.87B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 34.55%
Gross Profit Margin TTM: 48.40%
Debt To Equity: 0.24x
P/S TTM: 5.76x
P/B TTM: 2.54x
Market Cap: $1.87B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is IOVANCE BIOTHERAPEUTICS, INC. in?

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) operates in the Biological Products, (No Diagnostic Substances) industry.

What is IOVA's market cap?

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) has a market capitalization of $1.87B as of 2026-06-30.

What exchange does IOVA trade on?

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) trades on the Nasdaq.

Where is IOVANCE BIOTHERAPEUTICS, INC. incorporated?

IOVANCE BIOTHERAPEUTICS, INC. is incorporated in DE.